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Abstract
Background: As an oleaginous yeast, Yarrowia lipolytica is able to assimilate hydrophobic substrates. This led to
the isolation of several promoters of key enzymes of this catabolic pathway. Less is known about the behavior of Y.
lipolytica in large bioreactors using these substrates. There is therefore a lack of established know-how concerning
high cell density culture protocols of this yeast. Consequently, the establishment of suitable induction conditions is
required, to maximize recombinant protein production under the control of these promoters.
Results: Human interferon a2b (huIFN a2b) production in Yarrowia lipolytica was used as a model for the
enhancement of recombinant protein production under the control of the oleic acid (OA)-inducible promoter
POX2. Cell viability and heterologous protein production were enhanced by exponential glucose feeding, to
generate biomass before OA induction. The optimal biomass level before induction was determined (73 g L
-1), and
glucose was added with oleic acid during the induction phase. Several oleic acid feeding strategies were assessed.
Continuous feeding with OA at a ratio of 0.02 g OA per g dry cell weight increased huIFNa2b production by a
factor of 1.88 (425 mg L
-1) and decreased the induction time (by a factor of 2.6, 21 h). huIFN a2b degradation by
an aspartic protease secreted by Y. lipolytica was prevented by adding pepstatin (10 μM), leading to produce a 19-
fold more active huIFN a2b (26.2 × 10
7 IU mg
-1).
Conclusion: Y. lipolytica, a generally regarded as safe (GRAS) microorganism is one of the most promising non
conventional yeasts for the production of biologically active therapeutic proteins under the control of hydrophobic
substrate-inducible promoter.
Keywords: Yarrowia lipolytica, POX2 promoter, induction strategy, high cell density culture, recombinant human
interferon a?α?2b
Background
Protein quality, functionality, quantity and space time
yield are the most important factors to consider when
choosing the expression system for heterologous protein
production, especially for those of therapeutic interest.
In contrast to bacteria, yeasts have a great secretion
potential including a strict quality control with the abil-
ity to perform complex post transcriptional modification
[1,2]. In addition they are easier and less expensive to
work with than insect or mammalian cells, and are
easily adapted to fermentation processes. Saccharomyces
cerevisiae is the earliest and most widely used host for
the production of heterologous proteins; about 20% of
the approved recombinant biopharmaceutical are pro-
duced using this yeast [1]. However, it was found to
have some limitations such as low secretion capacities,
low product yield, and hyperglycosylation.
Ac o m p a r a t i v es t u d yb e t w e e nS. cerevisiae and the
alternative yeasts K. lactis, S. pombe, H. polymorpha,
and Y. lipolytica on their capacity to secrete active
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ined alternative yeasts were more efficient than S. cerevi-
siae. The most attractive yeast, especially in terms of
performance reproducibility, was Y. lipolytica [3].
This non conventional yeast has aroused a strong aca-
demic and industrial interest [4,5]. It is considered as
non pathogenic and “generally regarded as safe” (GRAS)
microorganism. Y. lipolytica was also distinguished for
its ability to secrete naturally several metabolites and
proteins in large amounts into the culture medium. But,
probably the most important characteristic of Y. lipoly-
tica as a host is the convenience of its secretory appara-
tus; high efficiency, co-translational pathway and low
overglycosylation, in some regards closer to that of
mammalian cells than to those of many yeasts [3,4,6].
Moreover, development of molecular and cellular tools
and a wide range of host strains make Y. lipolytica one
of the most attractive host for the expression of hetero-
logous proteins [6].
Much is known about its behavior in large bioreactors,
but most of the studies carried out have focused on the
production of oil or citric acid by single cells [4,7]. Only
a few reports have focused on the scale-up of recombi-
nant protein production in this yeast [8,9]. On the other
hand most of the reported proteins employed either
XPR2 or hp4d promoter expression system. However,
the use of these systems remains limited and may not
be compatible with some heterologous proteins or with
industrial culture conditions. The inducible XPR2 pro-
moter is active only at pH above 6 and its full induction
requires high levels of peptones in the culture medium
whereas the second promoter is constitutive; this can be
problematic when the product being expressed is toxic
to the host [6,9]. To overcome these limitations efforts
have been made to develop new alternative promoters.
The promoter of acyl-CoA oxidases (POX2) was isolated
by Juretzek et al. [10] in 2000; it was very strong and
highly inducible by fatty acids such as oleic acid and
repressed by glucose and glycerol. Despite these inter-
esting features, the use of the POX2 promoter for the
transcriptional control of foreign proteins was limited to
shaken flasks scale and, as oleic acid serves the purpose
of both inducer and source of carbon and energy, it is
not straightforward to distinguish in these studies
between the growth and protein production phases
when trying to define the ideal conditions for induction
[11,12]. There is therefore a lack of established know-
how concerning the fermentation of this expression
system.
In yeasts, the induction of gene expression by oleic
acid was initially attributed to activation sequences, such
as the oleate response elements found in the upstream
regions of genes encoding enzymes involved in the lipid
metabolic pathway [5,13]. One of the most important
key parameters in this expression system is the oleic
acid concentration. Monitoring and controlling this vari-
able are important because high levels of this inductor
substrate can be toxic to the cells and low levels of oleic
acid may not be enough to initiate the POX2 transcrip-
tion [14]. In order to maximize product yield and to
achieve a high and reproducible product quality, the
selection of the optimal oleic acid feeding strategy dur-
ing the induction phase, and the production in a bior-
eactor under controlled conditions is necessary.
Consequently, the establishment of suitable inducer con-
centration and the strategy used to conduct the culture
are a key issue that must be taken into account when
trying to maximize the production of heterologous pro-
teins during fermentation [15,16].
The aim of this study is to establish an efficient strat-
egy for heterologous proteins production at high cell
density of Y. lipolytica under the control of the oleic
acid inducible POX2 promoter. For this purpose huIF-
Na2b was used as a model.
huIFN a2b is one of the most studied types of inter-
feron a, and is encoded by an intronless gene. It is a
nonglycosylated 165-amino acid protein with two con-
served disulfide bonds: Cys1-Cys98 and Cys29-Cys138
[17]. It has been shown to have antiproliferative and
immunomodulatory effects on various cell types [18].
Recombinant huIFN a2b has been approved for use in
the treatment of more than 14 diseases worldwide,
including hairy-cell leukemia, condyloma acuminatum,
Kaposi’s sarcoma, hepatitis B and C [17,19].
In this study various feeding strategies were assessed
to optimize recombinant huIFN a2b by Y. lipolytica.
The influence of pre-induction biomass level on the
production of the target protein was also investigated.
This involved determining the effect of co-feeding stra-
tegies based on combinations of oleic acid and glucose
and of different ways of adding oleic acid on POX2
induction and cell biomass viability. This study also
aimed to find ways of preventing protein degradation
and to demonstrate the effect of pepstatin addition on
huIFNa2b degradation and biological activity.
Results and Discussion
Effect of glucose feeding during the induction phase
A three-stage fed-batch culture technique was adopted
for the production of huIFN a2b, using Y. lipolytica
JMY1852p. Cells were first grown in batch mode in
GNY medium with 20 g L
-1 glucose for 20 h, generating
about 15 g L
-1 (DCW) biomass (Figure 1A).
After glucose depletion, a fed-batch phase with an
exponential glucose feeding was started to generate high
cell density concomitantly with derepression of the
POX2 promoter. During the 20 h fed-batch culture, the
specific growth rate of cells was maintained at 0.1 h
-1
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than 110 g L
-1.2 0gL
-1 of oleic acid was then added to
initiate the induction phase. During this phase the bio-
mass decreased slightly and then remained almost con-
stant for the next 25 h (T = 65 h), after which it
decreased strongly. Further extension of the induction
phase led to cell lysis (Figure 1A).
Recombinant huIFN a2b production in the superna-
tant was checked at various time points by western blots
analysis. Protein quantification revealed that huIFN a2b
concentration peaked at 200 mg L
-1. Protein production
levels were highest during the first 9 h of induction,
decreasing thereafter (Figure 1B). Two forms of huIF-
Na2b were produced: the full-length cytokine (FL) and
a smaller, 14 kDa form probably resulting from proteo-
lytic degradation (PF, Figure 1B).
A typical growth inhibition profile following the
switch from glucose to oleic acid as the carbon source
was observed during this culture (Figure 1A). Oleic
acid does not seem to provide sufficient carbon and
energy to sustain efficient growth and huIFNa2b
production.
One approach to alleviate such problems is the use of
a multicarbon substrate in addition to the inducer. This
simple strategy increases the supply of energy to recom-
binant cells, decreasing the induction time and increas-
ing volumetric productivity [15].
Glucose was thus added at a constant flow rate of 4.8
gL
-1 during the induction phase. After an induction
period of 58 h, final biomass decreased only to 80 g L
-1
following feeding with a combination of the two sub-
strates, whereas it fell to 50 g L
-1 with OA alone (Figure
2). huIFNa2b concentration reached 212 mg L
-1 after
19 h of induction and contrary to the previous culture it
remained almost constant for the rest of the culture per-
iod. Mean huIFNa2b specific productivity was 0.04 mg
g
-1 DCW h
-1.
T h eu s eo fg l u c o s ea sac o - s u b s t r a t ea tal i m i t e dr a t e
decreased cell lysis and promoted Y. lipolytica growth,
as shown by the 33% increase in biomass and the 44%
increase in huIFNa2b yield. These results are compar-
able to the enhancement of cell growth and the dou-
bling of CD40 ligand production in Pichia pastoris
reported by McGrew and coworkers [20] when mixed
Figure 1 Time course of biomass (closed diamond), glucose concentration (open triangle), and residual oleic acid concentration (open
square) in a glucose exponential fed-batch culture. The solid vertical line indicates the start of feeding, and the dotted vertical line indicates
the addition of 20 g L
-1 oleic acid (A). Western blot analysis under reducing conditions with a polyclonal antibody against huIFN a2b (B). FL and
PF correspond to the full-length and proteolytically degraded forms of huIFN a2b, respectively. Time (h) is the number of hours after induction
with oleic acid. Bars indicate the mean values of two independent measurements.
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rather than methanol alone.
Effect of pre-induction biomass level
The data reported above show that cell growth almost
ceased in the induction phase, remaining very low until
the end of the culture period, although the decrease in
biomass was considerably reduced by the combined use
of glucose and oleic acid during induction (Figure 2).
This cell behavior may be due to space limitations when
cell concentration rises beyond 105 g L
-1.
Biomass at the start of the induction phase also played
a crucial role in heterologous protein production. The
effect of this parameter was investigated by setting up
another culture in similar conditions but inducing when
biomass reached 73 g L
-1. Constant glucose feeding was
applied during the induction phase. Biomass increased
continually, reaching a maximum value of 94 g L
-1 at 40
h of induction (Figure 2). In addition, both the DCW
yield on oleic acid and the amount of huIFN a2b were
higher than those when the culture was induced at a
biomass level of 105 g L
-1. By contrast, mean huIFN
a2b specific productivity was 39% higher than that for
the culture induced at a biomass of 105 g L
-1, possibly
due to a better oxygen supply.
There have been conflicting reports concerning the
effect of initial cell concentration before induction. Pin-
sach et al. [21] reported better E. coli growth and a
higher maximum specific activity of rhamnulose-1-phos-
phate aldolase at lower ratios of IPTG to biomass. By
contrast, Wang et al. [22] reported that low initial cell
concentration at the start of induction resulted in a
higher percentage of methanol assimilation into bio-
mass, at the expense of polygalacturonate lyase produc-
tion, in Pichia pastoris.
Optimization of the oleic acid addition profile
A series of bioreactor cultures with similar growth
phases on glucose was carried out to optimize the
induction phase further, yielding high levels of huIFN
a2b. Oleic acid was added at different initial concentra-
tions (5, 10 and 20 g L
-1) as a pulse or a continuous
feed at a rate of 1.25 g h
-1. For all cultures, biomass
before induction was about 73 g L
-1 and constant feed-
ing with glucose was maintained during the induction
phase at 4.8 g h
-1. Table 1 summarizes the induction
strategies adopted.
The different induction strategies generated different
growth features (Figure 3A): the values of (Yx/s)
obtained were 0.96, 3.06, 0.77 and 0 for strategies 1, 2, 3
and 4, respectively.
huIFN a2b was first detected in the medium after a 3
h lag phase, for all cultures (Figure 3B). The production
of this protein coincided with a slight decrease in bio-
mass. This lag phase probably corresponds to the time
required for the b oxidation of oleic acid. In Y. lipoly-
tica, b oxidation enzymes are produced in the cytoplasm
before being transported to the peroxisome, in which b
oxidation occurs [23].
In the presence of 20 g L
-1 oleic acid (strategy 1: con-
trol culture), huIFNa2b concentration rapidly reached
200 mg L
-1, gradually increasing thereafter to 240 mg L
-
Figure 2 Time course of biomass accumulation and huIFN a2b production during the induction phase. Induction with oleic acid as the
sole carbon source, and at an initial biomass level of 110 g L
-1 (closed diamond), induction using glucose as a cosubstrate with oleic acid and
at a biomass level of 105 g L
-1(closed triangle) and induction with glucose and oleic acid at an initial biomass level of 73 g L
-1 (open circle).
Dotted lines indicate huIFN a2b production. Bars are the mean values of three different measurements.
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tration fell rapidly to 9 g L
-1 at 9 h, remaining constant
thereafter, corresponding to an oleic acid/biomass ratio
of 0.12 (g g DCW
-1). Following the addition of oleic
acid to the medium at a concentration of 10 g L
-1 (strat-
egy 2), the highest levels detected of huIFN a2b was 240
mg L
-1. In these cultures, residual oleic acid concentra-
tion was 6-9 g L
-1 when the highest level of huIFN a2b
was reached. Nutrient limitation did not cause the ces-
sation of substrate uptake; in appropriate experiments,
supplementation with complex medium did not improve
oleic acid uptake (data not shown), probably due to the
metabolic stress caused by the overburdening of the cell
machinery at high oleic acid concentration.
Assuming that the amount of oleic acid transferred in
strategies 1 and 2 was too high for an efficient protein
production, the initial concentration of 20 g L
-1 was
a d d e da sf o u rp u l s e so f5gL
-1 oleic acid at 6 h inter-
vals, to avoid the accumulation of oleic acid in the med-
ium (strategy 3). huIFN a2b content reached with this
new strategy was considerably higher than that attained
with the previous strategies. Production increased
rapidly, reaching values of more than 315 mg L
-1 at 21
h of induction. Residual oleic acid concentration (Figure
3C) showed that the three first pulses were entirely con-
sumed within three hours of the pulse. Nevertheless, the
fourth pulse resulted in an accumulation of oleic acid
and a slight decrease in the recombinant protein pro-
duction level. No intracellular huIFN a2b was detected
during this culture, suggesting that secretion of the pro-
tein was not a limiting factor (data not shown).
A culture in which oleic acid was continually added to
the bioreactor, at a flow rate of 1.25 g h
-1 was then car-
ried out. This approach increased huIFNa2b production
to 425 mg L
-1 (Figure 3). This corresponds to twice the
amount of huIFNa2b produced following pulses with
oleic acid at 20 or 10 g L
-1. Residual oleic acid remained
below 2 g L
-1.
The amount of oleic acid added during strategy 1 was
clearly not optimal for the efficient production of huIF-
Na2b. However, when the same amount of oleic acid
was fed continuously, it resulted in 84% higher levels of
huIFNa2b specific production and a shorter induction
time. The ratio of oleic acid per gram of biomass
required to trigger huIFN a2b gene expression was only
one sixth that required when oleic acid was in excess
(strategy 1). These results suggest that the specific
amount of oleic acid added (in grams of oleic acid per
gram of DCW) and the way in which oleic acid is used
are the most important variables to be considered for
efficient induction. Furthermore, these results suggest
that residual oleic acid concentration plays an important
role in the process. These findings are consistent with
those of Gordillo et al. [14], who described the use of
oleic acid as an inducer for lipase production by Can-
dida rugosa. They reported that the initial concentration
of oleic acid had a major effect on final levels of lipolytic
activity. The maximum lipase yield was obtained at an
initial oleic acid concentration of 2 g L
-1.A th i g hc o n -
centrations, up to 8 g L
-1, specific productivity
decreased. They also showed that a minimal oleic acid
concentration was required (1 g L
-1)f o rl i p a s e
production.
Differences in protein production may be due to the
kinetics of inducer uptake. The transport of oleic acid to
t h es i t eo fb oxidation requires morphological and phy-
siological modifications. It was reported that an energy-
free transporter was required for oleic acid uptake
below a threshold of 10 μM, whereas for higher quanti-
ties oleic acid diffused freely. This might induce the
POX2 promoter fully over a very short period of time
[13]. Alternatively, these differences may be due to regu-
lation of the enzymes of the b oxidation loop, potentially
linked to substrate concentration. The presence of a
long-chain fatty acid substrate in the medium stimulates
POX2, and may repress POX3, which prefers short-
chain fatty acids. The uptake of large amounts of oleic
acid might therefore result in an accumulation of b-oxi-
dation intermediates, leading to POX2 repression and
an overload of subsequent b-oxidation steps [5].
Analysis and control of huIFN a2b proteolysis
For all the cultures described above, two main bands
were present on western blots: the upper band probably
corresponding to the full-length protein and the lower
band, at 14 kDa that could be a degraded product (Fig-
ure 1B). The ratio of the degraded form to the full-
length form was estimated by scanning western blots
Table 1 Comparison of kinetic parameters of huIFN a2b
production under different induction strategies
Parameter Strategy
123 4
St (g L
-1)2 0 1 0 2 0 2 0
Si (g L
-1)2 0 1 0 5
a
Induction period (h) 55 54 33 21
Sc (g L
-1) 11.14 6.3 13.8 17.3
X( gL
-1) 84.7 92.3 83.7 65
YX/S (g g
-1) 0.96 3.06 0.77 0
huIFNa2b (mg L
-1)
b 185 207 280 355
V (mg L
-1 h
-1) 3.36 3.83 8.5 16.9
P (mg g
-1 h
-1) 0.04 0.041 0.1 0.26
a Oleic acid was add by a continuous feeding, at a rate of 1.25 g h
-1
b Mean level of huIFNa2b
St: total oleic acid concentration, Si: initial oleic acid concentration, Sc:
substrate consumed. X: mean biomass level during induction, V: mean
volumetric production of huIFN a2b, P: mean specific production of huIFN
a2b
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portional to production yield, accounting for 20 to 30%
of total huIFN a2b despite the addition of casaminoa-
cids (0.1 g L
-1) every 24 h during the induction phase to
reduce proteolysis. The nature of the proteases behind
the cleavage of huIFN a2b was analyzed by zymography,
and proteolytic activity was determined. No proteases
were detected at the start of induction; these enzymes
were first detected at 3 h and increased in amount dur-
ing the production phase (Figure 4B and 4C). This clea-
vage was probably catalyzed by aspartic proteases,
because it was completely inhibited by pepstatin (data
not presented). The protease concerned is probably the
acidic protease AXP, which is secreted by Y. lipolytica
at low pH [6]. Furthermore, the XPR2 gene encoding
the alkaline protease (AEP), which presents a potent
threat to recombinant protein expression, was deleted
from the Pold strain used in this work.
The detected protease had a high level of proteolytic
activity (Figure 4B), the highest levels are coinciding to
the peak huIFN a2b synthesis. AXP is less active at pH
5, the pH used in this study. Large amounts of this
enzyme are produced to satisfy cellular requirements.
This might account for the strong protease activities
reported in all cultures.
huIFN a2b stability was studied by analyses on cell-free
culture supernatant and culture broth withdrawn from the
bioreactor and incubated in the presence of protein synthesis
inhibitors, as described in the materials and methods section.
huIFN a2b yield was significantly affected at pH 3 and 4
(Figure 4D). However, protein yields were also slightly
affected at pH values above 5, during the three days of incu-
bation at 28°C. These data confirm the sensitivity of huIFN
a2b to AXP and are consistent with the optimal pH for
AXP (around 3) and with data reported by Glover et al. [24]
who showed that this protease was less active at pH 5 to 6.
Figure 3 Time course of biomass concentration (A), huIFN a2b production (B), residual oleic acid concentration (C) and oleic acid to
biomass ratio (D) for the various strategies tested during the induction phase. St 1, St 2, St 3 and St 4 correspond to a 20 g L
-1 oleic acid
pulse, a 10 g L
-1 oleic acid pulse, 4 pulses of oleic acid, at 5 g L
-1 at 6 h intervals each, and continuous feeding with oleic acid at a rate of 1.25 g h
-1.
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tion of protein synthesis inhibitors to culture broth; this
suggests that both secreted and cell-associated proteases
contributed to huIFN a2b degradation. The reaction
was faster when cells were present (Figure 4D, line 8).
This may explain the culture profile observed in Figure
2, which shows a marked decrease in the amount of
huIFN a2b during cell lysis.
The problem of this proteolysis was overcome by per-
forming another culture, to which pepstatin was added
at a single dose of 10 μM at the beginning of the induc-
tion phase. The influence of pepstatin on growth, huIFN
a2b production and proteolytic activity is shown in Fig-
ure 5A. The addition of pepstatin to the culture medium
had no negative effect on growth rate, but increased bio-
mass slightly. Moreover, the target protein was pro-
duced in a single form, corresponding to the full-length
huIFN a2b (Figure 5B), suggestingt h a tt h ep r o t e o l y t i c
activity of the AXP protease was totally inhibited and
confirming that the lower band was not a truncated
polypeptide resulting from low levels of transcription.
However, no further increase in the amount of huIFN
a2b was obtained, with the maximum yield obtained
from this culture similar to that obtained without pep-
statin. One way to avoid protein degradation is to use
Po1f strain of Y. lipolytica that is lacking both AEP
(alkaline extracellular protease) and AXP [6].
huIFN a2b biological activity
The two forms of huIFN a2b were eluted, at the same
ionic strength, from cation exchange and gel filtration
columns, and had different estimated molecular weights
on silver nitrate-stained SDS PAGE gels (Figure 6).
N-Terminal sequencing was performed on both pro-
ducts. The sequence for the higher molecular weight band
(C-D-L-P-Q-T) corresponded to the N-terminal sequence
of huIFN a2b. The lower molecular weight band had the
following N-terminal sequence: I-S-L-F-S-C, correspond-
ing to the huIFNa2b protein lacking 23 amino acids. The
biological activity of the purified huIFN a2b was assessed
a n dc o m p a r e dw i t ht h a to ft h eh u I F Na2b produced in
Pichia pastoris. The huIFN a2b produced by Y. lipolytica
was biologically active. The level of biological activity was
found to depend on the level of proteolytic degradation of
Figure 4 Percentage huIFN a2b degradation (A) and protease activity (B) during the various induction strategies.A2 8k D ap r o t e a s e
detected in the supernatant for strategy 1 by zymography (C). huIFN a2b stability in the supernatant at various pH and in culture broth (D).
Lanes 1-7 correspond to pH 2, pH 3, pH 4, pH 5, pH 6, pH 7, pH 8 and lane 8 corresponds to broth culture with protein synthesis inhibitors.
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huIFN a2b predominated, the IFN produced by Y. lipoly-
tica was about twice (26.2 × 10
7 IU mg
-1)a st h a tp r o d u c e d
by Pichia pastoris.
It has been reported that only the second disulfide
bond is essential for the biological activity of huIFN. X-
ray crystallography showed that the huIFN a2b monomer
consisted of five helices, A to E, linked by one overhand
connection (AB loop) and three short segments. Two
regions of huIFN a2b were identified as critical for
biological activity: the high-affinity receptor binding site
1, consisting of residues on helix A, the AB loop and
helix E, and a second site formed from various residues
on helix A and helix C [25]. However, N-terminal
sequencing showed that helix A was degraded in the
cleaved form of huIFN a2b generated by Y. lipolytica.
This may account for the data presented in Table 2.
Conclusion
In conclusion, huIFN a2b production under control of
the POX2 promoter was significantly enhanced by an
optimized cofeeding and induction strategy. The lower
levels of cell lysis and higher levels of huIFNa2b when
glucose and oleic acid were supplied together suggest a
positive effect on POX2 expression, oleic acid transport
Figure 5 High-density culture of Y. lipolytica producing huIFN a2b. During induction, oleic acid was added continuously to the bioreactor
at a flow rate of 1.25 g h
-1; pepstatin was added, at a concentration of 10 μM, at the start of induction. Time course of biomass (open circle),
huIFN a2b production (closed circle) and protease activity (open triangle) (A). Western blot analysis showing huIFN a2b as a single full-length
form (B).
Figure 6 Silver-stained SDS-PAGE of samples collected during
the size exclusion purification step. P1, P2 and P3 represent the
pooled fractions tested for biological activity. FL: full-length form
and PF: proteolytically degraded form.
Table 2 Biological activity of huIFNa2b purified from Y.
lipolytica
Pool Composition Biological activity (IU mg
-1)
P1 Full-length: +++ 26.2 × 10
7
Cleaved form: +
P2 Mixture 7.47 × 10
7
P3 Full-length: +/- 1.41 × 10
7
Cleaved form: +++
+++: predominant; +: present; +/-: minor
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this cofeeding method further and to apply it for the pro-
duction of other heterologous proteins. This study
demonstrates that Y. lipolytica is an efficient host for the
production of biologically active therapeutic proteins.
Materials and methods
Strain
The Y. lipolytica strain JMY1852p is a prototrophic deri-
vative of JMY1852 [26], which harbors the JME1070
vector for expression of the codon-optimized huIFN
a2b gene under the control of the strong, OA-inducible
POX2 promoter. huIFNa2b secretion is directed by the
targeting sequence of the Y. lipolytica extracellular
lipase (Lip2p) pre-signal peptide.
Media
The recombinant strain was isolated on YPD-agar (yeast
peptone dextrose; 20 g L
-1 glucose, 10 g L
-1 yeast
extract, 10 g L
-1 peptone and 20 g L
-1 agar) plates. The
GNY minimal medium used in this study has been
described elsewhere [27]. Briefly this medium is com-
posed of basal salt solution (CaSO4 2H2O, 0.93 g L
-1;
K2SO4,1 8 . 2gL
-1; MgSO4 7H2O, 7.28 g L
-1; KOH, 4.4 g
L
-1; glucose, 20 g L
-1 and H3PO4 85%, 26.7 mL L
-1) sup-
plemented with 10 mg L
-1 FeCl3, 1 g L
-1 glutamate, 5
ml L
-1,5m lL
-1 of PTM1 oligo-elements solution
(CuSO4 5H 2O, 6 g L
-1;K I ,0 . 0 8gL
-1;M n S O 4 2H2O, 3
gL
-1 ;N a 2MoO4 2H2O, 0.2 g L
-1;H 3BO3,0 . 0 2gL
-1;
CoCl2 6H2O, 0.5 g L
-1;Z n C l 2,2 0gL
-1;F e S O 4 7H2O,
6.5 g L
-1.H 2SO4,5m LL
-1)a n d2m lL
-1 vitamin solu-
tions (Biotin, 8 μgL
-1;T h i a m i n ,2 0 0μgL
-1 and myo-
inositol 4 μgL
-1). The fed-batch solution contained 666
gL
-1 glucose and PTM1 (5 ml L
-1). Vitamins (2 ml L
-1)
were added to this solution after heat sterilization.
The stock solution (20% oleic acid, 0.5% Tween 20)
was subjected to sonication for 2 min with a BANDE-
LIN SONOPLUS sonicator (Berlin, Germany) for emul-
sification. Vitamins (2 ml L
-1) were added to the fed-
batch oleic acid solution.
Bioreactor cultures
The preinoculum culture was grown from a single col-
ony isolated on YPD-agar plates, in a 250 mL flask con-
taining 20 mL YPD medium and incubated overnight at
28°C, with shaking at 180 rpm, in a rotary shaker. The
preinoculum was transferred to a 2 L baffled flask con-
taining 200 mL of GNY medium and incubated at 28°C
for 12 h, with shaking at 180 rpm. For batch bioreactor
culture, the 200 mL of inoculum culture was transferred
aseptically to the bioreactor, which contained 2 L of
GNY medium. All cultures were carried out in a 5 L
stirred bioreactor (Infors, Bottmingen, Switzerland). The
pH was kept at 5 by adding 25% ammonia solution to
the reactor, and the temperature was maintained at 28°
C. Dissolved oxygen levels were kept at 40% of air
saturation, by adjusting the stirrer speed between 600
and 1000 rpm and supplying air and/or pure oxygen.
Bioreactor cultures were initiated by a batch growth
phase on glucose for approximately 20 h. The kinetic
parameters of cell growth were determined during this
phase. The coefficient yield of glucose conversion to
biomass (YX/S) was 0.75 g g
-1 (DCW on glucose), the
maximum specific growth rate (μmax) was 0.22 h
-1 and
the maintenance term (m) was 0.06 g g
-1 h
-1.
The end of the batch phase was identified by a
decrease in oxygen consumption rate. A simple mathe-
matical model based on mass balances and substrate
consumption kinetics was used to keep the specific
growth rate constant, to ensure exponential growth on
glucose [28]. Induction was performed by adding oleic
acid solution in various ways; unique pulses of 10 or 20
g/L, repetitive pulse of 5 g/L, and 1.25 g/L continuous
feeding depending on the experiment. Casaminoacids
(Bacto, France) were added to the fermentor at a con-
centration of 0.1 g L
-1 every 24 h during the induction
phase.
SDS-PAGE and western blot analysis
Sodium dodecyl sulfate polyacrylamide gel electrophor-
esis (SDS-PAGE) was performed in 15% polyacrylamide
gels under denaturating conditions, as described by
Laemmli [29]. After separation, proteins were stained
with either Coomassie brilliant blue R 250 or silver
nitrate.
For western blot analysis, 10 μl of diluted supernatant
were separated by SDS-PAGE and transferred onto
nitrocellulose membranes (Millipore, Bedford, MA,
USA) by electroblotting. The membranes were blocked
with PBS-5% skimmed milk, 0.1% Tween 20 overnight
at 4°C. Membranes were incubated for 1 hour with anti-
human IFNa2b polyclonal antibody produced in-house
and diluted to 1/200 followed by incubation with a goat
antimouse IgG peroxidase conjugated monoclonal anti-
body (Sigma, St Louis, USA) diluted at 1/5000. The
immunoreactive protein was visualized by ECL (GE
Healthcare, Uppsala, Sweden).
Analytical methods
Cell concentration was estimated from the optical den-
sity at 600 nm of an appropriately diluted culture sam-
ple. The correlation between OD600 and dry cell
weight was determined according to standard proto-
cols. After growth on medium containing oleic acid,
samples were extracted with a 2/5 (v/v)m i x t u r eo f
propanol/butanol before optical density determination.
One OD600 unit was equivalent to 0.35 g L
-1 dry cell
weight (DCW).
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matic assay (kit from Eurodiag, France). Oleic acid con-
centration was estimated by the colorimetric method,
based on a sulfo-phospho-vanillin reaction described by
Frings and Dum [30].
Protease activity was determined either by the colo-
metric method using azocasein as a substrate or by
zymography analysis. Culture supernatant (10 μl) was
mixed with 10 μl of a 2.5% azocasein solution and 70 μl
of 0.1 M phosphate-citrate buffer pH 5 then incubated
at 28°C for 1 h. The reaction was stopped by addition of
350 μl of 10% TCA (Trichloro acetic acid) solution.
Samples were centrifuged at 13.000 rpm for 10 min, and
then the absorbances of the supernatant were read at
440 nm against the blank. One unit of protease activity
was defined as the amount of enzyme required for an
increase in absorbance by 0.01 per hour. Zymography
analysis was carried out as previously described [27].
Briefly, 15% separating gels were mixed with 5 mg
casein; samples were treated with three-fold concen-
trated sample buffer. Gels were run at constant current
of 100 mV. Afterwards the gels were rinsed three times
with 2.5% (V/V) Triton X-100 and incubated overnight
in 50 mM acetate buffer pH 5 with or without inhibi-
tors. Gels were stained with Coomassie blue and then
destained until transparent zones caused by proteolytic
digestion of the protein substrate in the gel, are visible
against a blue background.
huIFN a2b production was determined by scanning
and using J-image software (Image-J 1.42) to analyze the
area of each band on western blot membranes. Concen-
trations were then calculated from a calibration curve
established with purified huIFN-a2b produced in Pichia
pastoris. The results shown are the mean values of three
scans.
The N-terminal amino acid sequences of the two of
huIFN-a2b forms were determined with the 420 A-130
A Derivatizer-Analyzer System (Applied Biosystems)
after hydrolysis in 6 M HCl at 110°C for 24 h. The N-
terminus of each form was sequenced by automated
Edman degradation, with an Applied Biosystems 492
Procise protein sequencer equipped with a PTH 140C
analyzer.
Proteolysis kinetics
For the analysis of huIFN a2b degradation in the cul-
ture broth, cycloheximide (20 mg L
-1) and chloramphe-
nicol (200 mg L
-1)w e r ea d d e dt o2 5m Lo ft h ec u l t u r e
broth taken from the bioreactor 9 h after induction, to
prevent de novo synthesis of proteins. Samples were
incubated in flasks at culture temperature (28°C), shaken
at 180 rpm. Samples were regularly withdrawn to deter-
mine the level of huIFN a2b degradation.
The influence of pH on huIFN a2b stability was inves-
tigated by analyzing culture supernatants collected dur-
ing bioreactor culture 20 h after induction. The pH was
adjusted to 2, 3, 4, 5, 6, 7 and 8, by adding 85% H3PO4
or 25% NH4OH before incubation at 28°C and 180 rpm.
Samples were withdrawn at various time points and
used for western blotting.
Purification of huIFN a2b
Culture broth collected at the end of the bioreactor
culture was centrifuged, clarified by 8 μm filtration
and desalted on a Sephadex G-25 column. huIFN a2b
was then purified on a cation exchange column, fol-
lowed by a Sephacryl S-100 column, as described else-
where [31].
Biological activity
The biological activity of the Y. lipolytica huIFNa2b
preparation was determined with the SEAP reporter
gene assay, as described by Meager [32]. HEK (human
embryo kidney) 293P cells transfected with a reporter
plasmid encoding the secreted embryonic alkaline phos-
phatase (SEAP) under the control of an IFN-inducible
promoter sequence (ISRE, interferon-stimulated
response element) were grown in 96-well plates, at a
density of 10
5 cells mL
-1 for 24 h and were stimulated
with various dilutions of huIFNa2b. After incubation for
a further 48 h, supernatants were collected and assayed
for SEAP activity, using para nitrophenyl phosphate as
the substrate. huIFN a2b reference (code: 95/566) was
used as a standard.
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